Amedeo Smart

Free Medical Literature Service

 

Amedeo

Andrology
  Free Subscription

Articles published in
Prostate
    November 2025
  1. QUARTA L, Bandini M, Corsini C, Cattafi F, et al
    Assessing Predictors of Failure After Bladder Neck Incision in Patients Who Developed Bladder Neck Stenosis Following Transurethral Surgery for Benign Prostatic Enlargement.
    Prostate. 2025;85:1424-1431.
    >> Share

    October 2025
  2. SCHMIDT J, Ralla B, Maxeiner A, Krediet J, et al
    Minimally Invasive Holmium Laser Enucleation of the Prostate (MiLEP) Vs. HoLEP: Retrospective Analysis of Perioperative Outcomes in a Propensity Score-Matched Cohort.
    Prostate. 2025;85:1299-1306.
    >> Share

    September 2025
  3. HUNT TC, Malshy K, Steidle M, Li A, et al
    Impact of Testosterone Recovery on Oncologic Outcomes in High-Risk, Localized Prostate Cancer.
    Prostate. 2025 Sep 9. doi: 10.1002/pros.70043.
    >> Share

  4. YOON SG, Noh TI, Shim JS, Park MG, et al
    The Efficacy of Transperineal Drainage for Treating Prostatic Abscess: A Comparative Analysis Against Conservative Management.
    Prostate. 2025;85:1161-1167.
    >> Share

    August 2025
  5. XU K, Khan A, Evancho P, Chu M, et al
    Analysis of the Increased Incidence of Aggressive Prostate Cancer After Prior Testicular Cancer.
    Prostate. 2025 Aug 16. doi: 10.1002/pros.70035.
    >> Share

  6. BASHI T, Kamshov S, Kidron A, Barnes S, et al
    Prevalence and Characteristics of Prostatic Utricles: A Retrospective MRI Study in Middle-Aged to Elderly Men.
    Prostate. 2025;85:1000-1004.
    >> Share

    July 2025
  7. ABDALI NT, Mohamed YS, Zaki HF, Ramadan LAA, et al
    Probenecid and Eugenol Mitigate Testosterone Induced Benign Prostatic Hyperplasia by Targeting Uric Acid-Induced Inflammation and Pro-Survival Pathways.
    Prostate. 2025 Jul 31. doi: 10.1002/pros.70026.
    >> Share

  8. DAGLI I, Uzel T, Canbolat MZ, Demirci A, et al
    The Mediterranean Diet and Benign Prostatic Hyperplasia: A Pathway to Improved Urinary Health.
    Prostate. 2025 Jul 6. doi: 10.1002/pros.70009.
    >> Share

    June 2025
  9. GRUTMAN AJ, Jing Y, Ng DK, Landis PK, et al
    History of Vasectomy Is not Associated With Prostate Cancer Progression in Men on Active Surveillance.
    Prostate. 2025 Jun 23. doi: 10.1002/pros.70001.
    >> Share

  10. WENG Y, Ji B
    Serum Levels of Prostate Specific Antigen, Free PSA, [-2]proPSA, fPSA/tPSA Ratio, Prostate Health Index, and Glycosylation Patterns of Free PSA in Patients With Benign Prostatic Hyperplasia Pharmacotherapy: Limitations and Future Directions.
    Prostate. 2025 Jun 22. doi: 10.1002/pros.70003.
    >> Share

  11. LI Y, Wu Z, Ma J, Liu X, et al
    Zinc Attenuates Prostate Hyperplasia and Inflammatory Injury in Obese Rats by Regulating Zinc Homeostasis and Inhibiting the JAK1/STAT3 Pathway.
    Prostate. 2025;85:767-776.
    >> Share

  12. SUN A, Rodriguez-Alvarez JS, Harper S, Khooblall P, et al
    The Prostate Microbiome Is Associated With Prostate Size and PSA Level, Independent of Age, in BPH Patients.
    Prostate. 2025;85:850-859.
    >> Share

    April 2025
  13. PAE S, Sakamoto S, Zhao X, Tamura T, et al
    LHRH Antagonists Restore Serum Testosterone Faster Than LHRH Agonists in Prostate Cancer Patients After Radiotherapy.
    Prostate. 2025 Apr 2. doi: 10.1002/pros.24899.
    >> Share

    March 2025
  14. GUERRA LHA, da Costa Castro NF, Jubilato FC, Marques LA, et al
    Coconut Oil Mitigates the Effects of Aging on the Mongolian Gerbil Prostate.
    Prostate. 2025;85:395-406.
    >> Share

    February 2025
  15. RINGLER R, Gangwish D, Horning P, Kuperus J, et al
    Does size matter? A single institution's comparison of Aquablation in prostates greater than or less than 150 mL.
    Prostate. 2025;85:140-147.
    >> Share

  16. ABDELAZIZ AY, Kishk MA, Meshref A, Elfayomy H, et al
    Safety and Efficacy of Intra-Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study.
    Prostate. 2025;85:243-251.
    >> Share

    December 2024
  17. KONG X, Dong Z, Hu W, Mi J, et al
    The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low-intensity extracorporeal shock wave.
    Prostate. 2024;84:1525-1536.
    >> Share

  18. ALVES BB, Gabrich P, Favorito LA
    Prospective results of the minimally invasive laser enucleation of the prostate (MiLEP).
    Prostate. 2024;84:1501-1505.
    >> Share

    November 2024
  19. WARREN CJ, Payne NG, Edmonds VS, Voleti SS, et al
    Quality of Chatbot Information Related to Benign Prostatic Hyperplasia.
    Prostate. 2024 Nov 8. doi: 10.1002/pros.24814.
    >> Share

    September 2024
  20. JIRASKO M, Vitak R, Pecen L, Pinkeova A, et al
    Serum levels of prostate specific antigen, free PSA, [-2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy.
    Prostate. 2024 Sep 27. doi: 10.1002/pros.24801.
    >> Share

  21. ZHANG P, Wang H, Li P, Fu X, et al
    Assessing state-of-the-art online large language models for patient education regarding prostatitis.
    Prostate. 2024;84:1173-1175.
    >> Share

    August 2024
  22. IGARASHI T, Mizoguchi S, Matsuoka K, Kamijo T, et al
    Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation.
    Prostate. 2024;84:1016-1024.
    >> Share

    July 2024
  23. LIU TT, Igarashi T, El-Khoury N, Ihejirika N, et al
    Benign prostatic hyperplasia nodules in patients treated with celecoxib and/or finasteride have reduced levels of NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, a mitochondrial protein essential for efficient function of the electron transport
    Prostate. 2024 Jul 14. doi: 10.1002/pros.24766.
    >> Share

    May 2024
  24. ZHANG Y, Zhou J
    Responses to queries concerning "Performance of large language models on benign prostatic hyperplasia frequently asked questions".
    Prostate. 2024 May 16. doi: 10.1002/pros.24748.
    >> Share

  25. DAUNGSUPAWONG H, Wiwanitkit V
    Large language models and benign prostatic hyperplasia frequently asked questions.
    Prostate. 2024 May 16. doi: 10.1002/pros.24719.
    >> Share

  26. HUA X, Zhang J, Chen J, Feng R, et al
    Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway.
    Prostate. 2024;84:666-681.
    >> Share

    April 2024
  27. ABID A, Piperdi H, Babar M, Loloi J, et al
    Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review.
    Prostate. 2024 Apr 24. doi: 10.1002/pros.24717.
    >> Share

  28. ROPER C, Slade A, Caras R, Shelton T, et al
    Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate.
    Prostate. 2024 Apr 1. doi: 10.1002/pros.24697.
    >> Share

  29. ZHANG Y, Dong Y, Mei Z, Hou Y, et al
    Performance of large language models on benign prostatic hyperplasia frequently asked questions.
    Prostate. 2024 Apr 1. doi: 10.1002/pros.24699.
    >> Share

    March 2024
  30. ZHAO X, Feng R, Chen J, Jiang Q, et al
    4-Octyl itaconate alleviates experimental autoimmune prostatitis by inhibiting the NLRP3 inflammasome-induced pyroptosis through activating Nrf2/HO-1 pathway.
    Prostate. 2024;84:329-341.
    >> Share

    February 2024
  31. KAMADA S, Sakamoto S, Kinoshita R, Zhao X, et al
    Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.
    Prostate. 2024 Feb 27. doi: 10.1002/pros.24679.
    >> Share

  32. SHIBAMORI K, Kyoda Y, Shindo T, Hashimoto K, et al
    Maternal diet during gestation affect prostatic tissue component in SHR/Izm offspring.
    Prostate. 2024;84:303-314.
    >> Share

    January 2024
  33. CAVANAUGH D, Urbanucci A, Mohamed NE, Tewari AK, et al
    Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS).
    Prostate. 2024 Jan 9. doi: 10.1002/pros.24656.
    >> Share

  34. WHITE JA, Kaninjing ET, Adeniji KA, Jibrin P, et al
    Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.
    Prostate. 2024 Jan 8. doi: 10.1002/pros.24662.
    >> Share

  35. JIN R, Forbes CM, Miller NL, Lafin J, et al
    Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
    Prostate. 2024 Jan 3. doi: 10.1002/pros.24661.
    >> Share

    December 2023
  36. LEE KS, Yoo JW, Kim DH, Jeon S, et al
    A prospective, randomized, open-label, parallel trial comparing the efficacy of alpha-blocker or 5alpha-reductase inhibitor withdrawal to continued combination therapy on the maintenance of lower urinary tract symptoms in men with benign prostatic hyp
    Prostate. 2023 Dec 27. doi: 10.1002/pros.24663.
    >> Share

  37. SCHNEIDER AJ, Serrell EC, Grimes M, Wang S, et al
    Histologic inflammation and collagen content are not positively correlated in human BPH.
    Prostate. 2023;83:1529-1536.
    >> Share

    November 2023
  38. MARIOTTI ACH, Heidrich V, Inoue LT, Coser EM, et al
    Urinary microbiota is associated to clinicopathological features in benign prostatic hyperplasia.
    Prostate. 2023 Nov 13. doi: 10.1002/pros.24649.
    >> Share

    October 2023
  39. DI H, Wen Y
    Vasectomy and risk of prostate cancer: A Mendelian randomization study and confounder analysis.
    Prostate. 2023 Oct 31. doi: 10.1002/pros.24646.
    >> Share

  40. ZHOU H, Xu M, Pan Y, Wang S, et al
    The association between several serum micronutrients and benign prostatic hyperplasia: Results from NHANES 2003-2006.
    Prostate. 2023 Oct 29. doi: 10.1002/pros.24641.
    >> Share

  41. HATA J, Matsuoka K, Akaihata H, Meguro S, et al
    The activated complement pathway in the fibrous process of benign prostatic hyperplasia.
    Prostate. 2023 Oct 25. doi: 10.1002/pros.24639.
    >> Share

  42. ZHANG Y, Peng R, Chen Z, Zhang W, et al
    Evidence for a causal effect of major depressive disorder, anxiety on prostatitis risk: A univariate and multivariate Mendelian randomization study.
    Prostate. 2023;83:1387-1392.
    >> Share

  43. WESTHOFEN T, Bensel M, Schlenker B, Becker A, et al
    The impact of previous inguinal mesh hernioplasty on oncological and patient-reported outcomes following radical prostatectomy.
    Prostate. 2023;83:1313-1322.
    >> Share

    September 2023
  44. FUJIWARA S, Kosaka T, Nishimoto Y, Kamisawa K, et al
    Prognostic significance of serum testosterone level in patients with castration-resistant prostate cancer treated with cabazitaxel.
    Prostate. 2023 Sep 3. doi: 10.1002/pros.24620.
    >> Share

    July 2023
  45. LV K, Yang G, Wu Y, Xia X, et al
    The causal effect of metabolic syndrome and its components on benign prostatic hyperplasia: A univariable and multivariable Mendelian randomization study.
    Prostate. 2023 Jul 16. doi: 10.1002/pros.24598.
    >> Share

    June 2023
  46. SEVIM M, Alkis O, Kartal IG, Kazan HO, et al
    Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
    Prostate. 2023;83:751-758.
    >> Share

  47. LI Z, Lao Y, Bai Y, Li W, et al
    Re: Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
    Prostate. 2023;83:896-897.
    >> Share

  48. LEBANI BR, Barcelos ADS, Gouveia DSES, Girotti ME, et al
    The role of transurethral resection of prostate (TURP) in patients with underactive bladder: 12 months follow-up in different grades of detrusor contractility.
    Prostate. 2023;83:857-862.
    >> Share

    May 2023
  49. LEE S, Yoo KH, Kim TS, Cho HJ, et al
    Characteristics of recurrent acute urinary retention in BPH patients in the United States: Retrospective analysis of US-based insurance claims database.
    Prostate. 2023;83:722-728.
    >> Share

  50. BABAR M, Loloi J, Tang K, Singh S, et al
    Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Prostate. 2023;83:713-721.
    >> Share

    April 2023
  51. BENGTSEN MB, Heide-Jorgensen U, Borre M, Norgaard M, et al
    Long-term risk of benign prostatic hyperplasia-related surgery and acute urinary retention in men treated with 5-alpha reductase inhibitor versus alpha-blocker monotherapy in routine clinical care.
    Prostate. 2023 Apr 14. doi: 10.1002/pros.24540.
    >> Share

    March 2023
  52. MIYAZAWA Y, Nakamura T, Takezawa Y, Shimizu N, et al
    A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS.
    Prostate. 2023 Mar 9. doi: 10.1002/pros.24514.
    >> Share

    February 2023
  53. BECK J, Rouleau M, Lemire F, Neveu B, et al
    Mass spectrometry redefines optimal testosterone thresholds in prostate cancer patients undergoing androgen deprivation therapy.
    Prostate. 2023 Feb 27. doi: 10.1002/pros.24501.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016